Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2022 | Real-world analysis of prevalence of fungal infections after cellular therapy

Eleni Gavriilaki • 12 Dec 2022
ASH 2022
General

Eleni Gavriilaki, MD, PhD, G Papanikolaou Hospital, Thessaloniki, Greece, discusses a real-world analysis which investigated the prevalence and outcomes of fungal disease in patients post-cellular therapy, and further highlights the importance of improving testing for fungal disease. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Eleni Gavriilaki

Endothelial injury syndromes in hematology: unifying the terminology 1:44
Endothelial injury syndromes in hematology: unifying the terminology
Eleni Gavriilaki • 13 Jun 2025
The Young EHA Research Meeting: cellular therapies and more 1:42
The Young EHA Research Meeting: cellular therapies and more
Eleni Gavriilaki • 13 Jun 2025
ATG versus ATLG as prophylaxis for graft-versus-host disease in alloSCT: a comparative study 1:45
ATG versus ATLG as prophylaxis for graft-versus-host disease in alloSCT: a comparative study
Eleni Gavriilaki • 13 Jun 2025
Safety and efficacy of autoSCT in systemic sclerosis 1:29
Safety and efficacy of autoSCT in systemic sclerosis
Eleni Gavriilaki • 9 Dec 2024

Related Videos

Using artificial intelligence to accelerate patient eligibility screening in clinical trials 1:52
Using artificial intelligence to accelerate patient eligibility screening in clinical trials
Aaron Gerds • 5 Dec 2025
Expanding CAR-T therapy to smaller centers to meet rising demand 1:28
Expanding CAR-T therapy to smaller centers to meet rising demand
Sunil Gupta • 5 Dec 2025
Replacing standard FISH panels with WGS in multiple myeloma 1:49
Replacing standard FISH panels with WGS in multiple myeloma
Francesco Maura • 8 Dec 2025
Results of a survey investigating fertility and outcomes after CAR T-cell therapy 1:13
Results of a survey investigating fertility and outcomes after CAR T-cell therapy
Florent Malard • 7 Dec 2025
The content of VJHemOnc is intended for healthcare professionals